Overview

Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-Bound Fibrin Sealant During Liver Resection

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
0
Participant gender:
All
Summary
This is a multi-centre, patient-blinded, intra-operatively randomised controlled trial. A total of 126 patients planned for an elective liver resection will be enrolled in 9 surgical centres. The primary objective of this study is to show that the collagen based haemostatic device Sangustop® is not inferior to a carrier-bound fibrin sealant (Tachosil®) in achieving haemostasis after hepatic resection.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Aesculap AG
Treatments:
Fibrin Tissue Adhesive
Hemostatics
Criteria
Inclusion:

- Age: > 18 years

- Gender: male / female

- Patients with an indication for liver resection (segmental or non-segmental)

- Willing and able to complete the clinical trial procedures, as described in the
protocol

- Signed written informed consent to participate in this clinical trial

Exclusion:

- Presence or sequelae of coagulation disorder, liver cirrhosis, Klatskin tumor

- Concurrent participation in another clinical trial with a medical device or medicinal
product or with interfering endpoints

- Concurrent or previous therapy with systemic pharmacologic agents promoting blood
clotting including but not limited to tranexamix acid, activated factor VII, and
aprotinine

- Known allergy or hypersensitivity to a component of the investigational treatments
Sangustop® or TachoSil®, to riboflavin or to proteins of bovine origin

- Pregnancy or breast feeding

- Inability to understand the nature and the extent of the trial and the procedures
required

- Missing signed written informed consent to participate in the study

Exclusion criteria to be checked during surgery (liver resection):

- Resection area estimated by operating surgeon < 16cm2

- Infected wound area

- Persistant major bleeding after primary haemostasis

- No bleeding after resection